Special Energy Sector Focus Report

Principal Solar, Inc.(OTCMKTS:PSWW) – Special Report:

As we mentioned in yesterday morning’s report, we are excited to be bringing a new item of interest to our readers’ attention this morning. With both the monetary and environmental costs of powering our increasingly demanding lives rising consistently, we believe it’s high time for a renewed interest in cleaner and more sustainable energy sources. That is one of the philosophies of the company that we are focusing upon today.

Principal Solar (PSWW) invests in, and/or acquires companies and technologies focused upon the next phase in consumer and commercial energy supply. Sustainability is the clear answer for a stable future, and renewable, clean energy will only continue to become more vital to our everyday lives, even as we continue to be, at least in part, reliant on more traditional sources.

For example, we are living in an age where most major automakers have acknowledged that fossil fuel will largely become a thing of the past well inside the next two decades. Take Cadillac for instance, which is no longer making new ICE models, and expects to be conducting all-EV sales by 2030. What that signifies to the rest of us, is that the times are certainly changing, and so must our consideration of energy related investment for the future.

PSWW also recognizes this, and has itself been strategically investing accordingly. For instance, in the past two years the company has taken a large stake in eTruck Transportation, on the order of more than a million dollars. The company recently posted a video presentation of eTruck’s production facilities, providing a look at its upcoming line of fully-electric Class 6 and Class 8 cargo vehicles. (>>Click Here to View the Walkthrough)

Committed to diversification, PSWW also seeks traditional energy opportunities, and has recently executed a letter of intent to purchase a controlling working interest in the leases, wells, and assets on the Minerva-Rockdale Oil Field (Milam County, Texas) from Winchester Oil & Gas LLC. A recent engineer’s report indicated proven reserves of more than 4 million barrels, with a current market value of well over a hundred million dollars. (>>View Press Announcement)

In addition to having these, and a number of other interests, PSWW itself has been rising steadily over the last month, with more than enough room for further upside potential. This is yet another factor drawing our attention to this intriguing opportunity to get in on the ground floor of a lot of of exciting developments.

Be sure to stay tuned to our reports on PSWW where we’ll dive even deeper on this high-potential stock in the weeks ahead, and continue below for our present opinion on the PSWW chart.
_____

PSWW CHART: 

The setup of the current PSWW chart is exhibiting many of the classic signs of a high-potential momentum play. We’ve had a lot of experience in reading OTC charts, and this one has been seriously ripening over the past month. With an RSI barreling into the Power Zone, and a MACD which had a bullish cross earlier this month and continues to diverge, we are excited to see the kind of conditions that even more upward pressure could create.


For More Information on PSWW, Please Visit:
pswwenergy.com

Why is $24B Orphan Drug leader bidding on Assets for this $7M Company?

Dear Reader,

Since the Orphan Drug Act was passed in 1983, the global market for development of drugs used to treat rare diseases has skyrocketed.  At that time, drug therapies for such diseases were rarely developed.  That has changed in today's multi-billion dollar market. 

Orphan diseases are often overlooked by the pharmaceutical industry, since there is very little financial incentive to treat illnesses which affect fewer than 200,000 people nationwide.  This includes ailments such as Cystic Fibrosis, Lou Gehrig’s disease, Huntington’s disease, and Tourette’s Syndrome.

Alexion Pharmaceuticals, a $24 Billion dollar Biopharma, has become the Orphan Drug leader with over $1.1 Billion in sales last year.  When the company finds a drug with leading-edge science behind it, they go after it

Savvy investors know just where to look to find the next big drug.  Court filings have revealed that Alexion has just received the winning bid on assets from this $7M microcap company, and Wall Street hasn’t caught on yet….until now

CLICK HERE TO LEARN MORE!

Blue Horseshoe Stocks: LLNKF Special Report

LLNKF
LiteLink Technologies, Inc. Special Report
(OTCMKTS:LLNKF) (CSE:LLT)

We’re very excited to bring this report to our readers this morning, due largely in part to our fondness for the space in which LLNKF primarily operates.

Digital wallets and peer-to-peer (P2P) financial services have rapidly hurtled to prominence in the current age of crypto-currencies, and cord-cutting in virtually every facet of modern life. LiteLink’s uBuck™ suite, currently in beta, promises to be a full-featured digital banking solution. Keep reading for more info.

LLNKF also recently acquired 1Shift Logisitics, a self-governing end-to-end logistics management solutions provider, which places the company in the position to take a bite out of another huge industry that only stands to grow in the current era of online transacting and direct-to-door shipment of material goods.

According to Market Research Future, the global e-wallet industry is presently worth more than a trillion dollars, and at a compound annual growth rate of 15%, could be valued north of two trillion in the next half decade. (pictured below)

LLNKF
LLNKF‘s uBuck™ platform is multi-pronged, and based on a prepaid voucher system. It includes the ability to execute fee and commission-free P2P fund transfers, withdrawal of cash from ATMs around the world, bill-pay, and even a specialized black card which can be used for purchases anywhere debit cards are accepted. The associated app, currently in closed beta testing, can manage multiple digital wallets of both fiat and decentralized currencies, and the system is fully encrypted with multiple factor authentication protocols to ensure safety. (Learn More about uBuck)

As far as 1Shift Logistics is concerned, the potential in the supply chain management industry is only as limited as commerce itself. End-to-end logistics requires effective data management and real-time collaboration between all parties involved to ensure a smooth operation. 1Shift, which as we stated was recently acquired by LLNKF, is in the final testing phases of its blockchain-powered platform to address these needs in innovative new ways. (Learn More about 1Shift )

We’re going to be very interested to track LLNKF stock as the company moves from the beta testing phase toward official launch of its two platforms which each operate in vibrant, rapidly growing industries. We encourage all of our readers to merely use this report as a starting point for your own due diligence on the industries mentioned here, as well as LLNKF’s place in those spaces. This is one company and stock that is absolutely dripping with upside potential. 
_____

FRESH NEWS:

VANCOUVER, British Columbia, May 16, 2019 (GLOBE NEWSWIRE) — LiteLink Technologies Inc. (“LiteLink”) (CSE:LLT) (OTC:LLNKF), a leader in logistics, artificial intelligence and digital payment solutions, announces that its wholly-owned subsidiary, uBUCK Technologies SEZC, has signed a Letter of Intent with Enthusiast Gaming Holdings Inc. (OTCQB:EGHIF) to be the official payment sponsor at the Enthusiast Gaming Live Expo, EGLX, in October 2019. Enthusiast is the largest publicly traded video game media and e-sports company in North America, and owns and operates the largest video game expo in Canada (EGLX). (>>View Full PR)
_____

LLNKF CHART:
Please take a couple of minutes to view the following video presentation



_____

Find Out More at LITELINKTECH.COM

Blue Horseshoe Stocks: AMPG Update

Amplitech Group, Inc. AMPG – Updates

We first began covering AMPG at the beginning of April. In the five weeks since then, the stock has made some solid progress on the chart, trading up from a low of .043, to its new high, just reached this week at .055. That’s a solid 28% increase, with no significant pullbacks along the way.

Our interest in the potential of AMPG was obviously justified, but we’re just getting started and we’re as excited as ever. As we’ve mentioned before, Amplitech is in the business of high-end signal amplification technologies with a veritable myriad of applications in a world which is becoming increasingly reliant upon wireless technology.

The transition has already begun- 5G is soon to be the gold standard in wireless communications, and AMPG is among the best OTC stocks we’ve run across to invest in the domestic 5G phenomenon. All of AMPG’s technology is Made in the USA.

With no toxic or long-term debt, and a float of just over 22M shares, AMPG is attractive to traders and longer-term investors alike. With a market cap of just $2.65M along with a pipeline of military-grade RF products and more in development, it’s also safe to say that AMPG is grossly undervalued. The company isn’t just resting on its laurels, either. AMPG recently added a highly experienced investment professional to act as an independent member of the board, chairing several special committees, and free up the CEO to more closely manage the company’s extreme growth potential and execution of strategy.

CEO Fawad Maqbool stated: “I am thrilled to have a seasoned investment banker, entrepreneur and investor such as Wayne committing his time and energy to our emerging company.  He should be invaluable to me in this next phase of our growth as it will allow me to better focus on our products, our customers and the opportunities that are emerging in the industries that we currently serve (custom and standard amplifiers for radar, missile systems, drones and many microwave communications systems), and will seek to serve in the future (innovative power and cryogenic amplifiers for 4G/5G wireless base stations, Wi-Fi for airlines, military jamming, quantum computing, internet of things, cyber security, life sciences and others).”  (>>View Full PR)
_____

AMPG CHART:

_____

For more information visit:
AmpliTechInc.com

OR CONTACT: Fawad Maqbool, CEO at (631) 521-7831
Twitter: twitter.com/AmpliTechAMPG
Instagram: instagram.com/amplitechampg
Facebook: facebook.com/AmpliTechInc

Blue Horseshoe Stocks: CHMJF Special Report

chemistree-technology-logo-1
Chemistree Technology, Inc. – Special Report
(OTCMKTS:CHMJF) (CSE:CHM)
.
Our primary order of business today is to profile a stock that we’ve never mentioned on our websites before, however, one that is actively involved in a market space that we’ve covered extensively. Cannabis has been at or near the top of our interests ever since our coverage of the legendary Green Rush of 2012, and continuing through to present-day.

Chemistree Technology Inc. is self-billed as an investment company which provides turn-key solutions for the regulated cannabis industry through the development of vertically integrated cannabis assets, including licensed cultivation, processing, distribution and retail facilities.

Perhaps the most impressive aspect of CHMJF is the rapidity with which the company has gone about executing its corporate strategy. In just the past year, it has acquired and/or developed cannabis assets in California and Washington State, with even more currently under construction.

In Washington State last May, the company acquired the Sugarleaf cannabis brand, along with the growing and processing facility that produces it, and all associated licenses. Sugarleaf branded cannabis is currently available in more than twenty retail locations, with plans to expand that to more than a hundred outlets in the next year. The company expects to generate roughly $2.7M in 2019 revenue for this facility alone.

In California, Chemistree has arranged a strategic collaboration with a Humboldt county cannabis-to-CBD processing company. CHMJF provided a $450K loan in exchange for immediate access to the California markets and the ability to purchase cannabis for processing at the facility, which it expects to bring in as much as $1.5M in revenue in 2019 alone.

Additionally, the company purchased 9.55 acres of land in cannabis-hotspot, Desert Hot Springs, California last year. It has completed the continuous-use permit, and is currently finalizing plans for two 64,000 square foot greenhouses and a 40,000 square foot manufacturing and distribution facility, subject to the approval of the city planner’s office.

These highlights only scratch the surface of what CHMJF has accomplished in just the last year, and hint at a promising finish to 2019, along with a bright future beyond. CHMJF has quickly become an area of special interest for us in the cannabis space.
_____

IMPORTANT! All readers should take the time to
>>VIEW this IN-DEPTH OVERVIEW of CHMJF<<

_____

MOST RECENT DEVELOPMENT: VANCOUVER, April 29, 2019 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that the Company has entered into a funding agreement with The Physician’s Choice CBD LLC of Phoenix, Arizona.

The Physician’s Choice CBD (“PCCBD”) is dedicated to research, development, and utilization of the highest quality of hemp-derived cannabidiol (CBD) combined with well-studied and effective supplements specific to help regulate and support various symptoms. The integration of extensive physician clinical experience combined with exhaustive expertise in the cannabis industry has led to the creation of The Physician’s Choice CBD. (>>View Full PR)

_____

CHMJF CHART:

_____

For More Information on CHMJF, visit:
chemistree.ca/
____

Don’t forget to check out THIS REPORT on CHMJF!

Get Our FREE Daily Reports!